These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 35677421)
1. Total controllability analysis discovers explainable drugs for Covid-19 treatment. Wei X; Pan C; Zhang X; Zhang W ArXiv; 2023 Jun; ():. PubMed ID: 35677421 [TBL] [Abstract][Full Text] [Related]
2. Total network controllability analysis discovers explainable drugs for Covid-19 treatment. Wei X; Pan C; Zhang X; Zhang W Biol Direct; 2023 Sep; 18(1):55. PubMed ID: 37670359 [TBL] [Abstract][Full Text] [Related]
3. Total network controllability analysis discovers explainable drugs for Covid-19 treatment. Wei X; Pan C; Zhang X; Zhang W Res Sq; 2023 Jul; ():. PubMed ID: 37503262 [TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
5. Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning. Ackerman EE; Shoemaker JE Viruses; 2020 Sep; 12(10):. PubMed ID: 32993136 [TBL] [Abstract][Full Text] [Related]
6. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification. Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419 [TBL] [Abstract][Full Text] [Related]
7. Insights into functional connectivity in mammalian signal transduction pathways by pairwise comparison of protein interaction partners of critical signaling hubs. Ramana CV Biomol Concepts; 2022 Jan; 13(1):298-313. PubMed ID: 36048718 [TBL] [Abstract][Full Text] [Related]
8. Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs. More SA; Patil AS; Sakle NS; Mokale SN Virology; 2021 Mar; 555():10-18. PubMed ID: 33421743 [TBL] [Abstract][Full Text] [Related]
9. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis. Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981 [TBL] [Abstract][Full Text] [Related]
10. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches. Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032 [TBL] [Abstract][Full Text] [Related]
11. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase. Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323 [TBL] [Abstract][Full Text] [Related]
12. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. Fiscon G; Conte F; Farina L; Paci P PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720 [TBL] [Abstract][Full Text] [Related]
13. Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis. Cheng F; Murray JL; Zhao J; Sheng J; Zhao Z; Rubin DH PLoS Comput Biol; 2016 Sep; 12(9):e1005074. PubMed ID: 27632082 [TBL] [Abstract][Full Text] [Related]
14. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications. Ting CT; Chen BS Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008 [TBL] [Abstract][Full Text] [Related]
15. Identification of phytochemical compounds of Zhang M; Zhang X; Pei J; Guo B; Zhang G; Li M; Huang L Heliyon; 2023 Mar; 9(3):e14029. PubMed ID: 36911881 [TBL] [Abstract][Full Text] [Related]
16. A network biology approach to identify crucial host targets for COVID-19. Barman RK; Mukhopadhyay A; Maulik U; Das S Methods; 2022 Jul; 203():108-115. PubMed ID: 35364279 [TBL] [Abstract][Full Text] [Related]
17. A Strategy Utilizing Protein-Protein Interaction Hubs for the Treatment of Cancer Diseases. Carels N; Sgariglia D; Junior MGV; Lima CR; Carneiro FRG; Silva GFD; Silva FABD; Scardini R; Tuszynski JA; Andrade CV; Monteiro AC; Martins MG; Silva TGD; Ferraz H; Finotelli PV; Balbino TA; Pinto JC Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003288 [TBL] [Abstract][Full Text] [Related]
18. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3- Dinda B; Dinda S; Dinda M Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465 [TBL] [Abstract][Full Text] [Related]
20. Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs. Eskandarzade N; Ghorbani A; Samarfard S; Diaz J; Guzzi PH; Fariborzi N; Tahmasebi A; Izadpanah K Comput Biol Med; 2022 Jul; 146():105575. PubMed ID: 35533462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]